| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 29,840 | 23,684 | 26,569 | 39,156 | | Cost of Revenue | 22,245 | 18,901 | 24,414 | 29,219 | | | Gross Profit | 7,595 | 4,783 | 2,155 | 9,937 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,013 | 8,700 | 7,808 | 7,949 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,582 | (3,917) | (5,653) | 1,988 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,586) | 1,541 | 2,983 | (794) | | Earnings Before Interest And Taxes | (2,239) | (2,376) | (2,670) | 1,194 | | Interest Expense | (629) | 629 | 706 | 876 | | Income Before Tax | (1,610) | (3,005) | (3,376) | 318 | | Income Tax Expense | 4 | 25 | (37) | 14 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,795) | (3,030) | (3,339) | 304 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,614) | (3,030) | (3,339) | 304 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,614) | ($3,030) | ($3,339) | $304 |
|
0.51% Nasdaq 
Income Statement
